These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30099422)

  • 1. ASIT as the component of bronchial asthma's therapy can improve the adherence to the treatment.
    Besh O; Besh D; Sorkopud O; Kondratiuk M; Slaba O; Zhakun I; Strilchuk L; Ładny JR; Rafałowicz B; Szarpak Ł; Gałązkowski R; Nadolny K
    Wiad Lek; 2018; 71(4):849-854. PubMed ID: 30099422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The clinical efficacy of allergen-specific immunotherapy with water-salt extracts and adjuvant allergens for atopic asthma with household sensitization].
    Ushakova DV; Nikonov EL
    Ter Arkh; 2017; 89(12):43-50. PubMed ID: 29411759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [OPTIMIZATION OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH BRONCHIAL ASTHMA: SELECTION FEATURES, PATIENT MONITORING AND EFFICACY].
    Besh L; Slyuzar Z; Matsyura O
    Georgian Med News; 2020 Sep; (306):67-72. PubMed ID: 33130649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ASIT therapy: advantages and adverse effects. own results and literature data.
    Besh OM; Besh DI; Sorokopud OO; Kondratiuk MO; Slaba OR
    Wiad Lek; 2018; 71(2 pt 1):341-345. PubMed ID: 29729170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Placebo effect in clinical trials with allergen-specific immunotherapy with inhalant allergens].
    Wedi B; Wieczorek D; Kapp A
    Hautarzt; 2017 Apr; 68(4):297-306. PubMed ID: 28194483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative analysis of the effectiveness of different methods of allergen-specific immunotherapy of bronchial asthma].
    Besh OM; Radchenko OM
    Wiad Lek; 2014; 67(2 Pt 2):387-90. PubMed ID: 25796879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
    Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contribution of sublingual immunotherapy to the achievement of control in birch-related mild persistent asthma: a real-life randomised trial.
    Marogna M; Braidi C; Bruno ME; Colombo C; Colombo F; Massolo A; Palumbo L; Compalati E
    Allergol Immunopathol (Madr); 2013; 41(4):216-24. PubMed ID: 23141837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The progress on allergen-specific immunotherapy for bronchial asthma].
    Liu HY; Xie LY; Zhou LF
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jun; 36(6):450-4. PubMed ID: 24103210
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
    Zhang X; Li MR; Wang C; Wang XN; Zhang HL; Lin J; Jin K; Li YC
    Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
    Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
    Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapy with a depigmented, polymerized vaccine of Olea europaea pollen allergens. Significantly reduces specific bronchial and skin test reactivity in sensitized patients after one year of treatment.
    Guerra F; Daza JC; Almeda E
    J Investig Allergol Clin Immunol; 2003; 13(2):108-17. PubMed ID: 12968395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
    Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
    JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
    Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
    Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled open study of sublingual immunotherapy for respiratory allergy in real-life: clinical efficacy and more.
    Marogna M; Spadolini I; Massolo A; Canonica GW; Passalacqua G
    Allergy; 2004 Nov; 59(11):1205-10. PubMed ID: 15461603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific allergen immunotherapy: effect on immunologic markers and clinical parameters in asthmatic children.
    Cevit O; Kendirli SG; Yilmaz M; Altintas DU; Karakoc GB
    J Investig Allergol Clin Immunol; 2007; 17(5):286-91. PubMed ID: 17982919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy with an extract of Olea europaea quantified in mass units. Evaluation of the safety and efficacy after one year of treatment.
    González P; Florido F; Sáenz de San Pedro B; de la Torre F; Rico P; Martín S
    J Investig Allergol Clin Immunol; 2002; 12(4):263-71. PubMed ID: 12926186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchial allergen provocation: a useful method to assess the efficacy of specific immunotherapy in children.
    Rosewich M; Arendt S; El Moussaoui S; Schulze J; Schubert R; Zielen S
    Pediatr Allergy Immunol; 2013 Aug; 24(5):434-40. PubMed ID: 23578317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
    Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
    Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.